Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311451750> ?p ?o ?g. }
- W4311451750 endingPage "252" @default.
- W4311451750 startingPage "242" @default.
- W4311451750 abstract "The Model for End-stage Liver Disease (MELD) and its sodium-corrected variant (MELD-Na) have created gender disparities in accessing liver transplantation. We aimed to derive and validate the Gender-Equity Model for liver Allocation (GEMA) and its sodium-corrected variant (GEMA-Na) to amend such inequities.In this cohort study, the GEMA models were derived by replacing creatinine with the Royal Free Hospital glomerular filtration rate (RFH-GFR) within the MELD and MELD-Na formulas, with re-fitting and re-weighting of each component. The new models were trained and internally validated in adults listed for liver transplantation in the UK (2010-20; UK Transplant Registry) using generalised additive multivariable Cox regression, and externally validated in an Australian cohort (1998-2020; Royal Prince Alfred Hospital [Australian National Liver Transplant Unit] and Austin Hospital [Victorian Liver Transplant Unit]). The study comprised 9320 patients: 5762 patients for model training, 1920 patients for internal validation, and 1638 patients for external validation. The primary outcome was mortality or delisting due to clinical deterioration within the first 90 days from listing. Discrimination was assessed by Harrell's concordance statistic.449 (5·8%) of 7682 patients in the UK cohort and 87 (5·3%) of 1638 patients in the Australian cohort died or were delisted because of clinical deterioration within 90 days. GEMA showed improved discrimination in predicting mortality or delisting due to clinical deterioration within the first 90 days after waiting list inclusion compared with MELD (Harrell's concordance statistic 0·752 [95% CI 0·700-0·804] vs 0·712 [0·656-0·769]; p=0·001 in the internal validation group and 0·761 [0·703-0·819] vs 0·739 [0·682-0·796]; p=0·036 in the external validation group), and GEMA-Na showed improved discrimination compared with MELD-Na (0·766 [0·715-0·818] vs 0·742 [0·686-0·797]; p=0·0058 in the internal validation group and 0·774 [0·720-0·827] vs 0·745 [0·690-0·800]; p=0·014 in the external validation group). The discrimination capacity of GEMA-Na was higher in women than in the overall population, both in the internal (0·802 [0·716-0·888]) and external validation cohorts (0·796 [0·698-0·895]). In the pooled validation cohorts, GEMA resulted in a score change of at least 2 points compared with MELD in 1878 (52·8%) of 3558 patients (25·0% upgraded and 27·8% downgraded). GEMA-Na resulted in a score change of at least 2 points compared with MELD-Na in 1836 (51·6%) of 3558 patients (32·3% upgraded and 19·3% downgraded). In the whole cohort, 3725 patients received a transplant within 90 days of being listed. Of these patients, 586 (15·7%) would have been differently prioritised by GEMA compared with MELD; 468 (12·6%) patients would have been differently prioritised by GEMA-Na compared with MELD-Na. One in 15 deaths could potentially be avoided by using GEMA instead of MELD and one in 21 deaths could potentially be avoided by using GEMA-Na instead of MELD-Na.GEMA and GEMA-Na showed improved discrimination and a significant re-classification benefit compared with existing scores, with consistent results in an external validation cohort. Their implementation could save a clinically meaningful number of lives, particularly among women, and could amend current gender inequities in accessing liver transplantation.Junta de Andalucía and EDRF." @default.
- W4311451750 created "2022-12-26" @default.
- W4311451750 creator A5009735497 @default.
- W4311451750 creator A5009873146 @default.
- W4311451750 creator A5010239298 @default.
- W4311451750 creator A5016729038 @default.
- W4311451750 creator A5022605799 @default.
- W4311451750 creator A5037685873 @default.
- W4311451750 creator A5037966091 @default.
- W4311451750 creator A5039083315 @default.
- W4311451750 creator A5051637842 @default.
- W4311451750 creator A5060601077 @default.
- W4311451750 creator A5086980043 @default.
- W4311451750 date "2023-03-01" @default.
- W4311451750 modified "2023-10-18" @default.
- W4311451750 title "Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study" @default.
- W4311451750 cites W1493363854 @default.
- W4311451750 cites W1987463134 @default.
- W4311451750 cites W1994682257 @default.
- W4311451750 cites W1999834979 @default.
- W4311451750 cites W2030635697 @default.
- W4311451750 cites W2069243984 @default.
- W4311451750 cites W2071007793 @default.
- W4311451750 cites W2072587220 @default.
- W4311451750 cites W2075815570 @default.
- W4311451750 cites W2084020470 @default.
- W4311451750 cites W2142457016 @default.
- W4311451750 cites W2158121233 @default.
- W4311451750 cites W2534956713 @default.
- W4311451750 cites W2748400966 @default.
- W4311451750 cites W2762658547 @default.
- W4311451750 cites W2775457963 @default.
- W4311451750 cites W2796307735 @default.
- W4311451750 cites W2802906787 @default.
- W4311451750 cites W2896043940 @default.
- W4311451750 cites W2907608712 @default.
- W4311451750 cites W2912919587 @default.
- W4311451750 cites W2942998776 @default.
- W4311451750 cites W2950184642 @default.
- W4311451750 cites W2953732988 @default.
- W4311451750 cites W2972628103 @default.
- W4311451750 cites W3027629963 @default.
- W4311451750 cites W3111854397 @default.
- W4311451750 cites W3176711790 @default.
- W4311451750 cites W3197129141 @default.
- W4311451750 cites W4206134146 @default.
- W4311451750 cites W4253289394 @default.
- W4311451750 cites W4281679166 @default.
- W4311451750 doi "https://doi.org/10.1016/s2468-1253(22)00354-5" @default.
- W4311451750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36528041" @default.
- W4311451750 hasPublicationYear "2023" @default.
- W4311451750 type Work @default.
- W4311451750 citedByCount "3" @default.
- W4311451750 countsByYear W43114517502023 @default.
- W4311451750 crossrefType "journal-article" @default.
- W4311451750 hasAuthorship W4311451750A5009735497 @default.
- W4311451750 hasAuthorship W4311451750A5009873146 @default.
- W4311451750 hasAuthorship W4311451750A5010239298 @default.
- W4311451750 hasAuthorship W4311451750A5016729038 @default.
- W4311451750 hasAuthorship W4311451750A5022605799 @default.
- W4311451750 hasAuthorship W4311451750A5037685873 @default.
- W4311451750 hasAuthorship W4311451750A5037966091 @default.
- W4311451750 hasAuthorship W4311451750A5039083315 @default.
- W4311451750 hasAuthorship W4311451750A5051637842 @default.
- W4311451750 hasAuthorship W4311451750A5060601077 @default.
- W4311451750 hasAuthorship W4311451750A5086980043 @default.
- W4311451750 hasBestOaLocation W43114517501 @default.
- W4311451750 hasConcept C126322002 @default.
- W4311451750 hasConcept C141071460 @default.
- W4311451750 hasConcept C159641895 @default.
- W4311451750 hasConcept C160798450 @default.
- W4311451750 hasConcept C201903717 @default.
- W4311451750 hasConcept C2777075537 @default.
- W4311451750 hasConcept C2779250428 @default.
- W4311451750 hasConcept C2779609443 @default.
- W4311451750 hasConcept C2780306776 @default.
- W4311451750 hasConcept C2911091166 @default.
- W4311451750 hasConcept C71924100 @default.
- W4311451750 hasConcept C72563966 @default.
- W4311451750 hasConceptScore W4311451750C126322002 @default.
- W4311451750 hasConceptScore W4311451750C141071460 @default.
- W4311451750 hasConceptScore W4311451750C159641895 @default.
- W4311451750 hasConceptScore W4311451750C160798450 @default.
- W4311451750 hasConceptScore W4311451750C201903717 @default.
- W4311451750 hasConceptScore W4311451750C2777075537 @default.
- W4311451750 hasConceptScore W4311451750C2779250428 @default.
- W4311451750 hasConceptScore W4311451750C2779609443 @default.
- W4311451750 hasConceptScore W4311451750C2780306776 @default.
- W4311451750 hasConceptScore W4311451750C2911091166 @default.
- W4311451750 hasConceptScore W4311451750C71924100 @default.
- W4311451750 hasConceptScore W4311451750C72563966 @default.
- W4311451750 hasIssue "3" @default.
- W4311451750 hasLocation W43114517501 @default.
- W4311451750 hasLocation W43114517502 @default.
- W4311451750 hasLocation W43114517503 @default.
- W4311451750 hasLocation W43114517504 @default.
- W4311451750 hasOpenAccess W4311451750 @default.
- W4311451750 hasPrimaryLocation W43114517501 @default.